Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency.

The Temple Lung Center is the first pulmonary program nationwide to integrate AI into routine lung screening, using specialized software as a core diagnostic tool. This advanced platform supports early detection, multidisciplinary review, and streamlined patient care pathways.

Through the Temple Healthy Chest Initiative’s dedicated lung screening program, every low-dose computed tomography (LDCT) scan is now processed using an AI-powered analytics platform designed to detect and flag abnormalities associated with lung nodules, COPD, coronary artery calcification, and early signs of lung cancer. By embedding this technology into clinical workflows, Temple ensures that no scan goes under-reviewed and no subtle disease is overlooked.

Temple’s AI-driven model not only advances patient care, it redefines what's possible in preventive pulmonary medicine. By combining breakthrough precision technology with a collaborative multidisciplinary care team, Temple is setting a new national standard for comprehensive, AI-supported screening and disease management.

Watch on Demand

The Temple Lung Center and CorelineSoft Present “LDCT+: A New Approach in Early Lung Disease Detection” to demonstrate how AI software elevates early detection and diagnostic outcomes in lung cancer screening.

LDCT+ - Leveraging AI and Spirometry for Better Patient Outcomes

This past year, the Temple Healthy Chest Initiative surpassed 10,000 patient lung cancer screenings. As the program continues to scale, it has introduced spirometry testing alongside LDCT scans to better detect undiagnosed COPD and airflow obstruction, leading to earlier treatment and better outcomes for patients. These tests are bundled into a single patient appointment for ease of access.

The updated GOLD 2023 Guidelines advise the inclusion of spirometry as a standard of care for accurate measurement of lung function, as evidence is emerging this leads to more appropriate treatment for COPD patients. 

Read more about Temple's lung screening process. To refer a patient for a screening, call 800-TEMPLE-MED (888-252-0754).